Search
00
GBAF Logo
trophy
Top StoriesInterviewsBusinessFinanceBankingTechnologyInvestingTradingVideosAwardsMagazinesHeadlinesTrends

Subscribe to our newsletter

Get the latest news and updates from our team.

Global Banking & Finance Review®

Global Banking & Finance Review® - Subscribe to our newsletter

Company

    GBAF Logo
    • About Us
    • Profile
    • Privacy & Cookie Policy
    • Terms of Use
    • Contact Us
    • Advertising
    • Submit Post
    • Latest News
    • Research Reports
    • Press Release
    • Awards▾
      • About the Awards
      • Awards TimeTable
      • Submit Nominations
      • Testimonials
      • Media Room
      • Award Winners
      • FAQ
    • Magazines▾
      • Global Banking & Finance Review Magazine Issue 79
      • Global Banking & Finance Review Magazine Issue 78
      • Global Banking & Finance Review Magazine Issue 77
      • Global Banking & Finance Review Magazine Issue 76
      • Global Banking & Finance Review Magazine Issue 75
      • Global Banking & Finance Review Magazine Issue 73
      • Global Banking & Finance Review Magazine Issue 71
      • Global Banking & Finance Review Magazine Issue 70
      • Global Banking & Finance Review Magazine Issue 69
      • Global Banking & Finance Review Magazine Issue 66
    Top StoriesInterviewsBusinessFinanceBankingTechnologyInvestingTradingVideosAwardsMagazinesHeadlinesTrends

    Global Banking & Finance Review® is a leading financial portal and online magazine offering News, Analysis, Opinion, Reviews, Interviews & Videos from the world of Banking, Finance, Business, Trading, Technology, Investing, Brokerage, Foreign Exchange, Tax & Legal, Islamic Finance, Asset & Wealth Management.
    Copyright © 2010-2026 GBAF Publications Ltd - All Rights Reserved. | Sitemap | Tags | Developed By eCorpIT

    Editorial & Advertiser disclosure

    Global Banking & Finance Review® is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

    Home > Headlines > Trump says pharmaceutical tariffs could reach 200%
    Headlines

    Trump says pharmaceutical tariffs could reach 200%

    Published by Global Banking & Finance Review®

    Posted on July 8, 2025

    3 min read

    Last updated: January 23, 2026

    Trump says pharmaceutical tariffs could reach 200% - Headlines news and analysis from Global Banking & Finance Review
    Why waste money on news and opinion when you can access them for free?

    Take advantage of our newsletter subscription and stay informed on the go!

    Subscribe

    Tags:Presidentfinancial communitytrade

    Quick Summary

    Trump proposes up to 200% tariffs on imported pharmaceuticals, giving drugmakers a year to adjust. The move aims to boost U.S. drug manufacturing.

    Trump Proposes Up to 200% Tariffs on Imported Pharmaceuticals

    By Andrea Shalal and Michael Erman

    WASHINGTON (Reuters) - U.S. President Donald Trump on Tuesday said he plans to announce tariffs on imported pharmaceuticals which could reach 200% but he would give drugmakers about one year "to get their act together."

    "We're going to give people about a year, a year and a half to come in and, after that, they're going to be tariffed," Trump told reporters, speaking at a meeting of his Cabinet at the White House where he also said he planned tariffs on semiconductor imports. 

    "If they have to bring the pharmaceuticals into the country ... they're going to be tariffed at a very, very high rate, like 200%. We'll give them a certain period of time to get their act together," he said. 

    "We're going to be announcing pharmaceuticals, chips and various couple of other things - you know, big ones," Trump told reporters, while announcing a new tariff rate for copper. He did not offer specifics on when the other announcements would come. 

    The Trump administration launched an investigation into the pharmaceutical industry in April as part of a bid to impose tariffs on the grounds that extensive reliance on foreign production of medicine is a national security threat. Trump has argued that the U.S. needs more drug manufacturing so it does not have to rely on other countries for medicines.

    The Commerce Department, which is conducting the investigation, has yet to issue a report.

    Details on pharmaceutical tariffs "will come at the end of the month," Commerce Secretary Howard Lutnick told CNBC after the Cabinet meeting.

    "With pharmaceuticals and semiconductors, those studies are being completed at the end of the month, and so the president will then set his policies then, and I’m going to let him wait to decide how he’s going to do it," Lutnick said.

    Drugmakers have argued that tariffs could increase the chance of shortages and reduce access for patients. They have lobbied Trump to phase in tariffs in hopes of reducing their impact and granting them extra time to shift manufacturing.

    The companies have global manufacturing footprints, and moving more production to the U.S. involves a major commitment of resources and could take years, they argue.

    "Every dollar spent on tariffs is a dollar that cannot be invested in American manufacturing or the development of future treatments and cures for patients," Alex Schriver, spokesman for industry group PhRMA, said in a statement.

    (Reporting by Andrea Shalal in Washington; writing by Susan Heavey and Michael Erman; editing by David Gregorio and Rosalba O'Brien)

    Key Takeaways

    • •Trump plans up to 200% tariffs on imported pharmaceuticals.
    • •Drugmakers have a year to adjust before tariffs are imposed.
    • •Tariffs could lead to shortages and reduced patient access.
    • •The Commerce Department is investigating the industry.
    • •PhRMA argues tariffs divert funds from U.S. manufacturing.

    Frequently Asked Questions about Trump says pharmaceutical tariffs could reach 200%

    1What is the proposed tariff rate on imported pharmaceuticals?

    President Trump stated that tariffs on imported pharmaceuticals could reach as high as 200%.

    2How long will drugmakers have to prepare for these tariffs?

    Trump mentioned that drugmakers would be given about one year to adjust before the tariffs are imposed.

    3What concerns do drugmakers have regarding the tariffs?

    Drugmakers argue that the tariffs could lead to shortages and reduce patient access to medications.

    4What is the status of the investigation into the pharmaceutical industry?

    The Commerce Department is conducting an investigation into the pharmaceutical industry, but has yet to issue a report.

    5What other industries might be affected by similar tariffs?

    In addition to pharmaceuticals, Trump mentioned that tariffs could also apply to semiconductors and other significant industries.

    More from Headlines

    Explore more articles in the Headlines category

    Image for Southeast Poland airspace closed due to 'unplanned military activity', FlightRadar24 says
    Southeast Poland airspace closed due to 'unplanned military activity', FlightRadar24 says
    Image for Exclusive-US plans initial payment towards billions owed to UN-envoy Waltz
    Exclusive-US plans initial payment towards billions owed to UN-envoy Waltz
    Image for Trump says good talks ongoing on Ukraine
    Trump says good talks ongoing on Ukraine
    Image for France to rally aid for Lebanon as it warns truce gains remain fragile
    France to rally aid for Lebanon as it warns truce gains remain fragile
    Image for Exclusive-US aims for March peace deal in Ukraine, quick elections, sources say
    Exclusive-US aims for March peace deal in Ukraine, quick elections, sources say
    Image for Ukraine's Zelenskiy calls for faster action on air defence, repairs to grid
    Ukraine's Zelenskiy calls for faster action on air defence, repairs to grid
    Image for Olympics-Italy's president takes the tram in video tribute to Milan transport
    Olympics-Italy's president takes the tram in video tribute to Milan transport
    Image for Goldman Sachs teams up with Anthropic to automate banking tasks with AI agents, CNBC reports
    Goldman Sachs teams up with Anthropic to automate banking tasks with AI agents, CNBC reports
    Image for Analysis-Hims' $49 weight-loss pill rattles investor case for cash-pay obesity market
    Analysis-Hims' $49 weight-loss pill rattles investor case for cash-pay obesity market
    Image for Big Tech's quarter in four charts: AI splurge and cloud growth
    Big Tech's quarter in four charts: AI splurge and cloud growth
    Image for Exclusive-Bangladesh PM front-runner rejects unity government offer, says his party set to win
    Exclusive-Bangladesh PM front-runner rejects unity government offer, says his party set to win
    Image for Azerbaijan issues strong protest to Russia over lawmaker's comments on Karabakh trial
    Azerbaijan issues strong protest to Russia over lawmaker's comments on Karabakh trial
    View All Headlines Posts
    Previous Headlines PostUS Justice Department scrambles to defend its about-face on release of Epstein files
    Next Headlines PostAnalysis-Trump's tariff deadline delay brings hope, confusion to trade partners, businesses